Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: papasimon / Re: Best and Worst from Shareholder Meeting re to 350 Millions

That's not a number that can be thrown out casually by the representative of PTSC's licensing partner. And certainly NOT in that setting.

If he did in fact say $350M, or $345M, it better represent a FACTUAL estimate that is VERY NEAR to the real number, or PTSC will have provided FALSE information at its shareholder meeting. Safe Harbor or not, that is NOT a forward looking statement, it is a statement of the current and past, and IMO would open PTSC to serious liability issues if it is false, or is not corrected immediately.

Share
New Message
Please login to post a reply